Kamari Pharma Raises $8 Million from the Sino-Israeli GIBF2 Fund

/PRNewswire/ -- Kamari Pharma announced today the completion of an $8 million investment by the Chinese fund GIBF2, managed by Dr. Shuki Gleitman, Prof. Shlomo...

Related Keywords

Germany ,Guangzhou ,Guangdong ,China ,Israel ,Rehovot ,Hamerkaz ,Chinese ,Israeli ,Carl Geng ,Shlomo Noy ,David Aviezer ,Shuki Gleitman ,Asaf Yarkoni ,Liora Braiman ,Avner Lushi ,Prnewswire Kamari Pharma ,Arkin Bioholdings ,York Stock Exchange ,Israel Biotech Investment Fund ,Protalix Biotherapeutics ,New York Stock Exchange ,Lichen Simplex Chronicus ,New York Stock ,South China ,Guangzhou Sino Israel Biotech Investment Fund ,The Guangzhou Sino Israel Biotech Investment Fund Gibf ,